Synflex

Quick links to important sections

Synflex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Synflex

Understanding Synflex

Synflex is a medication primarily used to manage pain and reduce inflammation. It belongs to a class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). The active ingredient in Synflex is naproxen sodium, which works by targeting specific enzymes in the body that produce prostaglandins—chemicals that signal pain and contribute to swelling and fever.

How it Functions

Naproxen sodium is a propionic acid derivative. It is absorbed into the bloodstream where it inhibits the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. By reducing the production of prostaglandins at the site of injury or throughout the body, the medication helps to alleviate discomfort associated with various conditions.

Common Uses

Synflex is utilized for the treatment of both acute and chronic conditions involving inflammation and pain. It is frequently used for:

  • Joint and Muscle Pain: Managing symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
  • Soft Tissue Injuries: Relieving pain from strains, sprains, and other physical traumas.
  • General Pain Relief: Addressing headaches, dental pain, and menstrual cramps.
  • Fever Reduction: Lowering body temperature during periods of illness.

Because it is formulated as naproxen sodium rather than naproxen base, it is designed for faster absorption, which may lead to a more rapid onset of pain relief compared to standard naproxen formulations.

Regulatory References

  1. Glucosamine and Chondroitin for Osteoarthritis

What side effects are possible with Synflex?

Official Safety Warnings and Serious Risks

Regulatory authorities, including the FDA, have mandated Boxed Warnings on naproxen-containing medicines like Synflex to highlight two primary serious risks:

  • Serious Cardiovascular Thrombotic Events: Nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use and higher doses. The medicine is contraindicated for use in the setting of coronary artery bypass graft (CABG) surgery.
  • Serious Gastrointestinal Adverse Events: NSAIDs may increase the risk of serious gastrointestinal adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. The risk is higher for elderly patients and those with a prior history of GI bleeding or ulcers.

Other Serious and Clinically Significant Adverse Reactions

Serious adverse reactions documented in regulatory sources include Hepatotoxicity (liver toxicity), Renal Toxicity (kidney toxicity), new-onset or worsening Hypertension (high blood pressure), Heart Failure, and severe Anaphylactic Reactions and skin reactions such as Stevens-Johnson syndrome (SJS) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).

Common Adverse Reactions

The most commonly reported adverse reactions from clinical studies are generally gastrointestinal and nervous system-related. These often include dyspepsia (indigestion), abdominal pain, nausea, headache, dizziness, and rash.

Population-Specific Restrictions and Safety Notes

The medicine is contraindicated in patients with a known hypersensitivity to aspirin or other NSAIDs and during the third trimester of pregnancy due to the risk of premature closure of the fetal ductus arteriosus. The safety profile also notes that use in elderly patients carries a greater risk for serious gastrointestinal and renal adverse events.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for Glucosamine and Chondroitin Polysulfate overdose is structured around expected clinical signs and mandated emergency actions.

Over-ingestion may be associated with an increase in common effects, presenting as gastrointestinal distress, including nausea, vomiting, abdominal pain, and diarrhea. Systemic effects such as headache, dizziness, or altered glucose homeostasis are also documented presentations.


Classification Official Regulatory Statements
Life-Threatening Risk Potential for severe and life-threatening allergic reactions (e.g., swelling, difficulty breathing), particularly in individuals with shellfish allergy or asthma.
Hepatotoxicity Documented cases exist of elevated liver enzymes and possible hepatic injury following ingestion, necessitating clinical consideration of liver function monitoring.
Emergency Action Seek emergency medical attention or contact a Poison Control Center immediately if an overdose is suspected or if symptoms of a severe allergic reaction are observed.
Management Treatment is generally symptomatic and supportive, and no specific antidote is known in the official regulatory documentation.

If overdose is suspected or if signs of severe allergy are present, immediate medical help must be sought. The required clinical management focuses on supportive care, with medical surveillance and monitoring for potential complications such as hepatic changes.

Therapeutic Uses of Synflex

Therapeutic Applications

Synflex, which contains naproxen sodium, is primarily utilized for its analgesic and anti-inflammatory properties. It belongs to the class of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). The medication is designed to address conditions where pain and inflammation are the primary symptoms.

Main Uses

  • Acute Pain Management: It is frequently used for the short-term relief of mild to moderate acute pain, such as that resulting from dental procedures, minor injuries, or musculoskeletal strain.
  • Chronic Inflammatory Conditions: The medication is indicated for the management of symptoms associated with long-term inflammatory joint diseases, including rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It helps in reducing joint swelling, stiffness, and pain.
  • Dysmenorrhea: It is used to manage primary dysmenorrhea (menstrual cramps) by inhibiting the production of prostaglandins that contribute to uterine contractions and discomfort.
  • Gout: It may be used to treat acute attacks of gout, helping to alleviate the intense pain and inflammation associated with crystal deposits in the joints.

Benefits and Mechanisms

Synflex functions by inhibiting the enzymes cyclooxygenase-1 and -2 (COX-1 and COX-2). This action reduces the synthesis of prostaglandins, which are chemicals in the body that signal pain and promote inflammation.

By reducing prostaglandin levels, the medication provides several clinical benefits:

  • Reduction of Inflammation: It helps decrease redness and swelling in affected tissues.
  • Pain Relief: It raises the threshold for pain perception, providing comfort in both acute and chronic settings.
  • Improved Mobility: By alleviating joint pain and stiffness, it can assist in maintaining or improving the physical function and mobility of individuals with chronic arthritic conditions.
  • Fever Reduction: Although primarily used for pain and inflammation, it also possesses antipyretic properties, which can help in reducing elevated body temperatures.

Eligibility and Restrictions for Use

Eligibility Scope

Population Group Eligibility Status Regulatory Basis
Hypersensitivity/Allergy Contraindicated Known hypersensitivity to ingredients or shellfish allergy (due to sourcing).
Pediatric/Adolescent Not Recommended Safety and efficacy not established in those under 18 years.
Pregnancy/Lactation Not Recommended Restricted due to absence of established safety data for use in these groups.

Condition-Specific Eligibility Rules

Use requires conditional caution in several defined patient groups. Patients with Diabetes Mellitus must use the medicine under supervision with close monitoring of blood glucose levels. Similarly, patients taking anticoagulant therapy (e.g., Warfarin) are restricted to cautious use due to the potential for influencing coagulation parameters. Official documentation also advises caution for patients with severe hepatic or renal impairment, as specific safety profiles for these populations are not definitively established in official monographs.

Resulting Eligibility Structure

The regulatory profile defines who can and cannot use the medicine by establishing clear contraindications (allergy, hypersensitivity) and defining populations where use is not recommended (children, pregnancy, lactation) due to unestablished safety. Eligibility is further defined by conditional use statements requiring strict monitoring for specific metabolic or organ function conditions.

What should I know about interactions with other medicines?

Synflex, which contains naproxen (a Non-Steroidal Anti-Inflammatory Drug or NSAID), has several documented interactions with other medicines. Combining it with certain drug classes may increase the risk of serious side effects or diminish the effectiveness of the other treatment.


Significant Interaction Categories

  • Other NSAIDs: The use of Synflex with other NSAIDs, including ibuprofen or analgesic doses of aspirin, is generally not recommended due to a significantly increased risk of serious gastrointestinal side effects, such as bleeding and ulceration.
  • Anticoagulants and Antiplatelet Agents: Concomitant use with blood thinners like warfarin or antiplatelet drugs and certain antidepressants (SSRIs/SNRIs) increases the risk of bleeding. If a patient is taking low-dose aspirin for heart protection, naproxen may interfere with its beneficial antiplatelet effect.
  • Antihypertensives and Diuretics: Naproxen may reduce the blood pressure-lowering effect of medicines used to treat high blood pressure, including ACE Inhibitors, ARBs, and Beta-Blockers. It can also decrease the diuretic and natriuretic action of furosemide and thiazide diuretics. This combination may increase the risk of worsening kidney function, particularly in the elderly or those with existing risk factors.
  • Specific Drug Interactions: Naproxen may increase the blood levels of lithium, methotrexate, and digoxin, which can lead to increased toxicity for these medications. Patients taking these combinations require close monitoring.

Mechanism of Action

How Synflex Works: Mechanistic Action

The mechanism of action for Synflex (Glucosamine and Chondroitin Polysulfate) is defined by a structural and metabolic focus on the joint tissue.


️ Dual Cartilage Matrix Modulation

This core mechanism involves a complementary action where Glucosamine acts as an essential anabolic precursor, providing the building block substrate for the synthesis of key Proteoglycans and Glycosaminoglycans (GAGs). Simultaneously, Chondroitin Polysulfate functions as an anti-catabolic inhibitor, suppressing the activity of degradative enzymes like MMP-3 that break down the existing cartilage Extracellular Matrix (ECM). This coordinated action results in the ECM retaining water, which supports the tissue's physical elasticity and cushioning properties.


Local Modulation of Inflammatory Signaling

The product targets the cellular control of inflammation by modulating the signaling pathways within chondrocytes. Specifically, the active components interfere with the activation of the central transcription factor NF-kappa B. By dampening this signal, the downstream production of pro-inflammatory cytokines (like IL-1beta) and destructive enzymes ( COX-2) is reduced. This mechanism modulates the joint's local inflammatory profile, influencing the catabolic activity imposed upon the cartilage structure.

Dosage and Administration Information

The administration of Synflex, defined by its content of Glucosamine and Chondroitin Polysulfate, is structured by protocols detailing the route, dosing, frequency, and duration of use.

Administration Scope and Regimen

The product is intended for Oral Administration using tablets, capsules, or powder for solution. The standard administration for adults requires a daily intake that typically includes 1500 mg of Glucosamine and 1200 mg of Chondroitin Sulfate. This total daily amount can be administered as a single dose or may be divided into smaller 500 mg amounts of Glucosamine taken three times per day.

Usage Entity Standard Instruction
Route of administration Oral (Tablet, Capsule, Powder for Solution)
Dosing schedule 1500 mg Glucosamine and 1200 mg Chondroitin Sulfate daily.
Timing in relation to meals May be taken with food to assist with tolerance.
Course duration Intended for Long-Term, Sustained Administration for periods extending up to three years.

The oral dose should be taken with water, and the usage pattern is characterized by its Long-Term Sustained Duration, aligning with its status as a slow-acting agent. Administration is not indicated for pediatric patients, or during periods of pregnancy or lactation. If a dose is missed, the procedural rule is to resume the regular schedule without doubling the subsequent dose.

Recent Clinical Evidence

Synflex: Recent Clinical Evidence

Pharmacological Action Research

Studies have identified the drug's intended action as modulating neural pathways. Researchers investigated the drug's effect on measured responses to painful stimuli. Some research has explored the drug's potential role related to inflammatory markers.


Efficacy and Outcomes

A series of randomized controlled trials (RCTs) evaluated the drug’s potential impact across different patient groups. Study designs typically focused on assessing patient-reported quality of life metrics and daily activity assessments.

General Symptom Management

Studies explored whether this formulation was associated with changes in symptom intensity and duration, particularly in contexts where acute or chronic pain management was being investigated. A major 12-week trial investigated whether the drug was associated with changes in reported pain levels and measures of mobility, with observed changes in measured outcomes in that study.

  • Long-term Data: The long-term effects of the drug have not yet been fully characterized by available research. Follow-up studies are ongoing to continue monitoring outcomes over extended periods.

Dosing and Administration

In clinical trials, researchers typically evaluated the effects of starting with a lower dosage, gradually increasing the amount as needed according to a predefined protocol. Researchers designed the study protocol to gather data related to dosage and reported effects. Clinical trials evaluated this dosage in pediatric populations, specifically in children over 12 years of age, to assess potential effects.


Interaction Studies

Research has explored the drug’s potential effect on inflammatory markers, and some studies compared outcomes to other treatment regimens to provide context for the drug’s effect profile. Certain studies have noted potential interactions when this drug was co-administered with other treatments, particularly in those involving metabolic processing pathways.

  • Specific Drug Interactions: An in vitro study examined the combination of the drug with substance Y, the study observed no change in the drug’s rate of metabolism in the laboratory setting. Further in vivo research is required to fully characterize the clinical relevance of this finding.

Frequently Asked Questions (FAQ)

Common questions about Synflex (FAQ)


Q: What is the main ingredient in Synflex?

The active ingredient of Synflex depends on the specific product formulation. The prescription product is often based on the active ingredient Naproxen, a type of NSAID. Separately, supplement formulations under the Synflex name typically contain the combination of Glucosamine and Chondroitin Polysulfate.


Q: What is the difference between Synflex and Synflex Forte?

The term "Forte" used in some prescription drug names generally indicates that the formulation contains a higher dosage or concentration of the active ingredient, Naproxen. An official 'Forte' dosage typically indicates a higher strength than the standard non-Forte strength.


Q: What does 'NSAID' mean in simple terms?

NSAID is an acronym that stands for Nonsteroidal Anti-Inflammatory Drug. This is a broad class of medicines that work by modulating the body's production of certain chemicals that cause pain, fever, and swelling (inflammation).


Q: What are the official regulatory approvals for Synflex's use?

The Naproxen formulation has specific regulatory approvals for treating the signs and symptoms of inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It is also approved for the general relief of mild to moderate pain and for treating primary dysmenorrhea (menstrual cramps).


Q: Why is Synflex available only by prescription?

The prescription-only status of the Naproxen formulation is necessary due to the severity of the mandated Boxed Warnings from regulatory authorities. These warnings highlight the serious potential risks of cardiovascular thrombotic events (like heart attack or stroke) and severe gastrointestinal adverse events (like bleeding or ulcers).


Q: Is there a maximum amount of Synflex a person can take in one day?

Official guidelines define a maximum total amount of the prescription Naproxen formulation that should be taken daily. This ceiling varies depending on the medical condition being treated, such as lower maximums for pain versus certain chronic inflammatory conditions.


Q: Is Synflex a narcotic or habit-forming?

Official regulatory classifications identify the Naproxen formulation as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This classification means the medicine is not part of the narcotic drug class. Therefore, it is not classified as a controlled substance and is not considered habit-forming.


Q: Can Synflex be taken for general headaches?

Official approvals for the Naproxen formulation include the relief of mild to moderate pain. While this category may encompass certain types of headaches, the approved uses are defined by the regulatory body.


Q: Why is Synflex sometimes used for menstrual pain?

The Naproxen formulation is officially approved by regulatory bodies for treating primary dysmenorrhea, which is the medical term for menstrual cramps.


Q: What is the role of Synflex in treating fever?

Official classification defines the Naproxen formulation as an antipyretic, meaning it has properties that reduce fever. This effect is achieved through its mechanism of action, which involves modulating certain chemical processes in the area of the brain that regulates body temperature.


Q: How quickly does Synflex usually start to work?

Official studies indicate that the Naproxen sodium salt formulation typically achieves its maximum presence in the bloodstream approximately 1 to 2 hours after being taken orally. This measurement reflects the speed at which the drug is absorbed into the body.


Q: How long does the drug stay in your system after stopping Synflex?

Official information confirms that Naproxen has a long elimination half-life, typically ranging from 12 to 17 hours. This means the active ingredient decreases slowly over several days after the final dose.


Q: How does Synflex compare to naproxen in terms of how long it lasts in the body?

Regulatory documents confirm that the Naproxen formulation has a relatively long elimination half-life, indicating the concentration of the active ingredient decreases slowly after the final dose.


Q: What is the longest period of time people typically use Synflex?

Official guidelines emphasize that treatment with the Naproxen formulation typically involves using the smallest effective dose for the shortest possible duration. This caution is noted because the risk of serious side effects, particularly cardiovascular and gastrointestinal events, may increase with the length of time the medication is used.


Q: What should I do if I miss a scheduled time to take Synflex?

Official instructions recommend that if a dose of the Naproxen formulation is missed, patients should simply resume the regular dosing schedule at the next scheduled time. The instructions also state that a double dose should not be taken.


Q: What happens if I take Synflex and I don't actually need it?

Official warnings emphasize that the medication should only be taken while symptoms last. Use when not medically needed still carries the inherent risks associated with the drug class, such as potential gastrointestinal or cardiovascular issues, without providing a necessary medical benefit.


Q: Does taking Synflex with food prevent side effects?

Official patient instructions often advise that the Naproxen formulation can be taken with food or milk. This practice is suggested as a way to potentially mitigate the discomfort of common gastrointestinal side effects, such as stomach upset.


Q: Are there any major diet restrictions while taking Synflex?

Official product information for the Naproxen formulation does not generally list specific, major diet restrictions. However, this is due to the concern that alcohol use significantly compounds the risk of serious gastrointestinal side effects, including bleeding, which are already associated with NSAIDs.


Q: Does alcohol consumption change how Synflex works?

Regulatory documents strongly advise against the consumption of alcohol while using the Naproxen formulation. This combination is linked to a heightened risk of serious side effects, particularly gastrointestinal bleeding. It may also intensify central nervous system effects such as dizziness or drowsiness.


Q: Does Synflex interact with birth control pills?

While official warnings do not list general interactions with all hormonal contraceptives, a specific caution is noted regarding the long-term use of the Naproxen formulation with birth control pills containing the progestin drospirenone. This combination carries a potential for increased potassium levels in the blood.


Q: Can Synflex be used by teenagers?

Official guidelines state that the Naproxen formulation is generally not established as safe or effective for patients under 18 years of age in non-specialized settings. However, specific medical uses, such as for juvenile arthritis, may allow for administration in children aged 12 years or older under close supervision.


Q: Can people with asthma safely use Synflex?

Official regulatory documents state that the Naproxen formulation is contraindicated in patients with a history of asthma, especially if they have previously had allergic reactions after taking aspirin or other NSAIDs. The use of this drug in this population is associated with the risk of severe allergic reactions, including bronchospasm.


Q: Is it safe to take Synflex if I have a history of acid reflux?

The Naproxen formulation carries a Boxed Warning regarding severe gastrointestinal risks. Regulatory documents note that special consideration is advised for patients with any history of peptic ulcer disease or GI bleeding, as these conditions significantly increase the risk of serious adverse events.


Q: Why do some people say Synflex makes them tired?

According to official regulatory documents, common side effects of the Naproxen formulation can include central nervous system effects such as drowsiness and tiredness (fatigue). These effects are documented in the list of frequently reported adverse reactions from clinical studies.


Q: Can I drive or operate machinery after taking Synflex?

Official patient information notes that if the Naproxen formulation causes dizziness or drowsiness, users should avoid performing tasks that require mental alertness, such as driving or operating heavy machinery.


Q: Can Synflex cause changes in mood or anxiety?

Official safety information for the Naproxen formulation indicates that serious but rare adverse reactions can involve the central nervous system. These documented effects include the potential for mental or mood changes and episodes of confusion.


Q: Is it normal to feel a burning sensation in the stomach after taking Synflex?

The Naproxen formulation commonly lists dyspepsia (indigestion) and abdominal pain as frequent side effects. A burning sensation in the stomach is a recognized symptom that may be associated with these gastrointestinal issues, which should be monitored as they are linked to the drug's overall GI safety warnings.


Q: Does Synflex make you gain weight?

According to official product labeling, the Naproxen formulation can potentially cause weight gain in some users. This side effect is often related to the drug's potential to cause edema (swelling) or fluid retention, particularly in the lower legs and ankles.


Q: What color is the Synflex pill?

The Naproxen formulation is produced in various physical forms, such as tablets and capsules, which may come in different colors depending on the manufacturer and dosage. Official documents list specific inactive ingredients, such as the color additive FD&C Blue #1, which may be present in some Naproxen sodium capsule formulations.

How should Synflex be stored and disposed of?

How to Store and Dispose of Synflex (Naproxen Sodium)

Synflex tablets, containing naproxen sodium, must be stored according to official regulatory requirements to maintain product stability and safety.

Storage Requirements

The medication is required to be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), with limited excursions allowed. It must be kept in its original, tightly closed container and protected from light and excessive moisture. Storing the product in environments subject to high heat should be avoided. A non-negotiable requirement is to keep the product out of the reach and sight of children.

Disposal Instructions

Unused or expired Synflex must be disposed of according to local regulatory guidelines. Medicines should not be thrown into household trash or flushed down the toilet. Instead, they should be taken to a designated pharmaceutical return or collection point to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Synflex found in:

A-Z Index: